Advertisement
Advertisement
Mind Medicine’s Accelerated Phase 3 Trials and Strong Financial Position Signal Promising Future
PremiumRatingsMind Medicine’s Accelerated Phase 3 Trials and Strong Financial Position Signal Promising Future
9d ago
MindMed Reports Q3 2025 Financial Progress
Premium
Company Announcements
MindMed Reports Q3 2025 Financial Progress
9d ago
Mind Medicine Reports Q3 2025 Financial Results
Premium
Company Announcements
Mind Medicine Reports Q3 2025 Financial Results
10d ago
Mind Medicine 18.375M share Spot Secondary priced at $12.25
PremiumThe FlyMind Medicine 18.375M share Spot Secondary priced at $12.25
17d ago
MindMed Highlights Strategic Focus in New Presentation
Premium
Company Announcements
MindMed Highlights Strategic Focus in New Presentation
18d ago
Mind Medicine announces offering of common shares and warrants, no amount given
Premium
The Fly
Mind Medicine announces offering of common shares and warrants, no amount given
18d ago
MindMed Issues Inducement Grant to New Employee
PremiumCompany AnnouncementsMindMed Issues Inducement Grant to New Employee
1M ago
Mind Medicine initiated with an Outperform at LifeSci Capital
Premium
The Fly
Mind Medicine initiated with an Outperform at LifeSci Capital
1M ago
3 Best Stocks to Buy Now, 10/13/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 10/13/2025, According to Top Analysts
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100